Global Liposomes Drug Delivery Market Research Report 2023

Publisher Name :
Date: 07-Jan-2023
No. of pages: 95
Inquire Before Buying

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

Highlights

The global Liposomes Drug Delivery market was valued at US$ 3335.2 million in 2022 and is anticipated to reach US$ 6549.6 million by 2029, witnessing a CAGR of 10.0% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.

Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liposomes Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes Drug Delivery.

The Liposomes Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Liposomes Drug Delivery market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liposomes Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Johnson & Johnson

- Gilead Sciences

- Pacira

- Sun Pharmaceutical

- Luye Pharma

- Sigma-Tau Group

- Fudan-Zhangjiang

- Teva Pharmaceutical

- CSPC

- Novartis

- Kingond Pharm

- Spectrum Pharmaceuticals

- Shanghai New Asia

Segment by Type

- Liposomal Doxorubicin

- Liposomal Amphoteracin B

- Liposomal Paclitaxel

- Others

Segment by Application

- Fungal Infection Therapy

- Cancer & Tumor Therapy

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Liposomes Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Liposomes Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Liposomes Drug Delivery Market Research Report 2023

Table of Contents
1 Oil-Free Compressors Market Overview
1.1 Product Definition
1.2 Oil-Free Compressors Segment by Power
1.2.1 Global Oil-Free Compressors Market Value Growth Rate Analysis by Power 2022 VS 2029
1.2.2 50 Horsepower and Below
1.2.3 50-100 Horsepower
1.2.4 100 Horsepower and Above
1.3 Oil-Free Compressors Segment by Application
1.3.1 Global Oil-Free Compressors Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Food and Beverage
1.3.3 Electronics Industry
1.3.4 Pharmaceutical Industry
1.3.5 Oil and Gas
1.3.6 Automobile
1.3.7 Auto Ancillaries
1.3.8 Power Generation
1.3.9 Others
1.4 Global Market Growth Prospects
1.4.1 Global Oil-Free Compressors Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Oil-Free Compressors Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Oil-Free Compressors Production Estimates and Forecasts (2018-2029)
1.4.4 Global Oil-Free Compressors Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Oil-Free Compressors Production Market Share by Manufacturers (2018-2023)
2.2 Global Oil-Free Compressors Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Oil-Free Compressors, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Oil-Free Compressors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Oil-Free Compressors Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Oil-Free Compressors, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Oil-Free Compressors, Product Offered and Application
2.8 Global Key Manufacturers of Oil-Free Compressors, Date of Enter into This Industry
2.9 Oil-Free Compressors Market Competitive Situation and Trends
2.9.1 Oil-Free Compressors Market Concentration Rate
2.9.2 Global 5 and 10 Largest Oil-Free Compressors Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Oil-Free Compressors Production by Region
3.1 Global Oil-Free Compressors Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Oil-Free Compressors Production Value by Region (2018-2029)
3.2.1 Global Oil-Free Compressors Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Oil-Free Compressors by Region (2024-2029)
3.3 Global Oil-Free Compressors Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Oil-Free Compressors Production by Region (2018-2029)
3.4.1 Global Oil-Free Compressors Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Oil-Free Compressors by Region (2024-2029)
3.5 Global Oil-Free Compressors Market Price Analysis by Region (2018-2023)
3.6 Global Oil-Free Compressors Production and Value, Year-over-Year Growth
3.6.1 North America Oil-Free Compressors Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Oil-Free Compressors Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Oil-Free Compressors Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Oil-Free Compressors Production Value Estimates and Forecasts (2018-2029)
4 Oil-Free Compressors Consumption by Region
4.1 Global Oil-Free Compressors Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Oil-Free Compressors Consumption by Region (2018-2029)
4.2.1 Global Oil-Free Compressors Consumption by Region (2018-2023)
4.2.2 Global Oil-Free Compressors Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Oil-Free Compressors Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Oil-Free Compressors Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Oil-Free Compressors Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Oil-Free Compressors Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Oil-Free Compressors Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Oil-Free Compressors Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Oil-Free Compressors Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Oil-Free Compressors Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Power
5.1 Global Oil-Free Compressors Production by Power (2018-2029)
5.1.1 Global Oil-Free Compressors Production by Power (2018-2023)
5.1.2 Global Oil-Free Compressors Production by Power (2024-2029)
5.1.3 Global Oil-Free Compressors Production Market Share by Power (2018-2029)
5.2 Global Oil-Free Compressors Production Value by Power (2018-2029)
5.2.1 Global Oil-Free Compressors Production Value by Power (2018-2023)
5.2.2 Global Oil-Free Compressors Production Value by Power (2024-2029)
5.2.3 Global Oil-Free Compressors Production Value Market Share by Power (2018-2029)
5.3 Global Oil-Free Compressors Price by Power (2018-2029)
6 Segment by Application
6.1 Global Oil-Free Compressors Production by Application (2018-2029)
6.1.1 Global Oil-Free Compressors Production by Application (2018-2023)
6.1.2 Global Oil-Free Compressors Production by Application (2024-2029)
6.1.3 Global Oil-Free Compressors Production Market Share by Application (2018-2029)
6.2 Global Oil-Free Compressors Production Value by Application (2018-2029)
6.2.1 Global Oil-Free Compressors Production Value by Application (2018-2023)
6.2.2 Global Oil-Free Compressors Production Value by Application (2024-2029)
6.2.3 Global Oil-Free Compressors Production Value Market Share by Application (2018-2029)
6.3 Global Oil-Free Compressors Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Atlas Copco
7.1.1 Atlas Copco Oil-Free Compressors Corporation Information
7.1.2 Atlas Copco Oil-Free Compressors Product Portfolio
7.1.3 Atlas Copco Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Atlas Copco Main Business and Markets Served
7.1.5 Atlas Copco Recent Developments/Updates
7.2 Ingersoll Rand
7.2.1 Ingersoll Rand Oil-Free Compressors Corporation Information
7.2.2 Ingersoll Rand Oil-Free Compressors Product Portfolio
7.2.3 Ingersoll Rand Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Ingersoll Rand Main Business and Markets Served
7.2.5 Ingersoll Rand Recent Developments/Updates
7.3 KAESER
7.3.1 KAESER Oil-Free Compressors Corporation Information
7.3.2 KAESER Oil-Free Compressors Product Portfolio
7.3.3 KAESER Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.3.4 KAESER Main Business and Markets Served
7.3.5 KAESER Recent Developments/Updates
7.4 Gardner Denver
7.4.1 Gardner Denver Oil-Free Compressors Corporation Information
7.4.2 Gardner Denver Oil-Free Compressors Product Portfolio
7.4.3 Gardner Denver Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Gardner Denver Main Business and Markets Served
7.4.5 Gardner Denver Recent Developments/Updates
7.5 Fusheng
7.5.1 Fusheng Oil-Free Compressors Corporation Information
7.5.2 Fusheng Oil-Free Compressors Product Portfolio
7.5.3 Fusheng Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Fusheng Main Business and Markets Served
7.5.5 Fusheng Recent Developments/Updates
7.6 Kobelco
7.6.1 Kobelco Oil-Free Compressors Corporation Information
7.6.2 Kobelco Oil-Free Compressors Product Portfolio
7.6.3 Kobelco Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Kobelco Main Business and Markets Served
7.6.5 Kobelco Recent Developments/Updates
7.7 Boge
7.7.1 Boge Oil-Free Compressors Corporation Information
7.7.2 Boge Oil-Free Compressors Product Portfolio
7.7.3 Boge Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Boge Main Business and Markets Served
7.7.5 Boge Recent Developments/Updates
7.8 Aerzen
7.8.1 Aerzen Oil-Free Compressors Corporation Information
7.8.2 Aerzen Oil-Free Compressors Product Portfolio
7.8.3 Aerzen Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Aerzen Main Business and Markets Served
7.7.5 Aerzen Recent Developments/Updates
7.9 Mitsui
7.9.1 Mitsui Oil-Free Compressors Corporation Information
7.9.2 Mitsui Oil-Free Compressors Product Portfolio
7.9.3 Mitsui Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Mitsui Main Business and Markets Served
7.9.5 Mitsui Recent Developments/Updates
7.10 Hitachi
7.10.1 Hitachi Oil-Free Compressors Corporation Information
7.10.2 Hitachi Oil-Free Compressors Product Portfolio
7.10.3 Hitachi Oil-Free Compressors Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Hitachi Main Business and Markets Served
7.10.5 Hitachi Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Oil-Free Compressors Industry Chain Analysis
8.2 Oil-Free Compressors Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Oil-Free Compressors Production Mode & Process
8.4 Oil-Free Compressors Sales and Marketing
8.4.1 Oil-Free Compressors Sales Channels
8.4.2 Oil-Free Compressors Distributors
8.5 Oil-Free Compressors Customers
9 Oil-Free Compressors Market Dynamics
9.1 Oil-Free Compressors Industry Trends
9.2 Oil-Free Compressors Market Drivers
9.3 Oil-Free Compressors Market Challenges
9.4 Oil-Free Compressors Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Liposomes Drug Delivery Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Liposomes Drug Delivery Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Liposomes Drug Delivery Market Competitive Situation by Manufacturers in 2022
Table 4. Global Liposomes Drug Delivery Sales (K Vials) of Key Manufacturers (2018-2023)
Table 5. Global Liposomes Drug Delivery Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Liposomes Drug Delivery Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Liposomes Drug Delivery Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Liposomes Drug Delivery Average Price (USD/Vial) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Liposomes Drug Delivery, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Liposomes Drug Delivery, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Liposomes Drug Delivery, Product Type & Application
Table 12. Global Key Manufacturers of Liposomes Drug Delivery, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes Drug Delivery as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Liposomes Drug Delivery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Liposomes Drug Delivery Sales by Region (2018-2023) & (K Vials)
Table 18. Global Liposomes Drug Delivery Sales Market Share by Region (2018-2023)
Table 19. Global Liposomes Drug Delivery Sales by Region (2024-2029) & (K Vials)
Table 20. Global Liposomes Drug Delivery Sales Market Share by Region (2024-2029)
Table 21. Global Liposomes Drug Delivery Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Liposomes Drug Delivery Revenue Market Share by Region (2018-2023)
Table 23. Global Liposomes Drug Delivery Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Liposomes Drug Delivery Revenue Market Share by Region (2024-2029)
Table 25. North America Liposomes Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Liposomes Drug Delivery Sales by Country (2018-2023) & (K Vials)
Table 27. North America Liposomes Drug Delivery Sales by Country (2024-2029) & (K Vials)
Table 28. North America Liposomes Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Liposomes Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Liposomes Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Liposomes Drug Delivery Sales by Country (2018-2023) & (K Vials)
Table 32. Europe Liposomes Drug Delivery Sales by Country (2024-2029) & (K Vials)
Table 33. Europe Liposomes Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Liposomes Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Liposomes Drug Delivery Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Liposomes Drug Delivery Sales by Region (2018-2023) & (K Vials)
Table 37. Asia Pacific Liposomes Drug Delivery Sales by Region (2024-2029) & (K Vials)
Table 38. Asia Pacific Liposomes Drug Delivery Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Liposomes Drug Delivery Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Liposomes Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Liposomes Drug Delivery Sales by Country (2018-2023) & (K Vials)
Table 42. Latin America Liposomes Drug Delivery Sales by Country (2024-2029) & (K Vials)
Table 43. Latin America Liposomes Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Liposomes Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Liposomes Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Liposomes Drug Delivery Sales by Country (2018-2023) & (K Vials)
Table 47. Middle East & Africa Liposomes Drug Delivery Sales by Country (2024-2029) & (K Vials)
Table 48. Middle East & Africa Liposomes Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Liposomes Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Liposomes Drug Delivery Sales (K Vials) by Type (2018-2023)
Table 51. Global Liposomes Drug Delivery Sales (K Vials) by Type (2024-2029)
Table 52. Global Liposomes Drug Delivery Sales Market Share by Type (2018-2023)
Table 53. Global Liposomes Drug Delivery Sales Market Share by Type (2024-2029)
Table 54. Global Liposomes Drug Delivery Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Liposomes Drug Delivery Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Liposomes Drug Delivery Revenue Market Share by Type (2018-2023)
Table 57. Global Liposomes Drug Delivery Revenue Market Share by Type (2024-2029)
Table 58. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2018-2023)
Table 59. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2024-2029)
Table 60. Global Liposomes Drug Delivery Sales (K Vials) by Application (2018-2023)
Table 61. Global Liposomes Drug Delivery Sales (K Vials) by Application (2024-2029)
Table 62. Global Liposomes Drug Delivery Sales Market Share by Application (2018-2023)
Table 63. Global Liposomes Drug Delivery Sales Market Share by Application (2024-2029)
Table 64. Global Liposomes Drug Delivery Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Liposomes Drug Delivery Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Liposomes Drug Delivery Revenue Market Share by Application (2018-2023)
Table 67. Global Liposomes Drug Delivery Revenue Market Share by Application (2024-2029)
Table 68. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2018-2023)
Table 69. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2024-2029)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 73. Johnson & Johnson Liposomes Drug Delivery Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Gilead Sciences Corporation Information
Table 76. Gilead Sciences Description and Business Overview
Table 77. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 78. Gilead Sciences Liposomes Drug Delivery Product
Table 79. Gilead Sciences Recent Developments/Updates
Table 80. Pacira Corporation Information
Table 81. Pacira Description and Business Overview
Table 82. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 83. Pacira Liposomes Drug Delivery Product
Table 84. Pacira Recent Developments/Updates
Table 85. Sun Pharmaceutical Corporation Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 88. Sun Pharmaceutical Liposomes Drug Delivery Product
Table 89. Sun Pharmaceutical Recent Developments/Updates
Table 90. Luye Pharma Corporation Information
Table 91. Luye Pharma Description and Business Overview
Table 92. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 93. Luye Pharma Liposomes Drug Delivery Product
Table 94. Luye Pharma Recent Developments/Updates
Table 95. Sigma-Tau Group Corporation Information
Table 96. Sigma-Tau Group Description and Business Overview
Table 97. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 98. Sigma-Tau Group Liposomes Drug Delivery Product
Table 99. Sigma-Tau Group Recent Developments/Updates
Table 100. Fudan-Zhangjiang Corporation Information
Table 101. Fudan-Zhangjiang Description and Business Overview
Table 102. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 103. Fudan-Zhangjiang Liposomes Drug Delivery Product
Table 104. Fudan-Zhangjiang Recent Developments/Updates
Table 105. Teva Pharmaceutical Corporation Information
Table 106. Teva Pharmaceutical Description and Business Overview
Table 107. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical Liposomes Drug Delivery Product
Table 109. Teva Pharmaceutical Recent Developments/Updates
Table 110. CSPC Corporation Information
Table 111. CSPC Description and Business Overview
Table 112. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 113. CSPC Liposomes Drug Delivery Product
Table 114. CSPC Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 118. Novartis Liposomes Drug Delivery Product
Table 119. Novartis Recent Developments/Updates
Table 120. Kingond Pharm Corporation Information
Table 121. Kingond Pharm Description and Business Overview
Table 122. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 123. Kingond Pharm Liposomes Drug Delivery Product
Table 124. Kingond Pharm Recent Developments/Updates
Table 125. Spectrum Pharmaceuticals Corporation Information
Table 126. Spectrum Pharmaceuticals Description and Business Overview
Table 127. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 128. Spectrum Pharmaceuticals Liposomes Drug Delivery Product
Table 129. Spectrum Pharmaceuticals Recent Developments/Updates
Table 130. Shanghai New Asia Corporation Information
Table 131. Shanghai New Asia Description and Business Overview
Table 132. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 133. Shanghai New Asia Liposomes Drug Delivery Product
Table 134. Shanghai New Asia Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Liposomes Drug Delivery Distributors List
Table 138. Liposomes Drug Delivery Customers List
Table 139. Liposomes Drug Delivery Market Trends
Table 140. Liposomes Drug Delivery Market Drivers
Table 141. Liposomes Drug Delivery Market Challenges
Table 142. Liposomes Drug Delivery Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Liposomes Drug Delivery
Figure 2. Global Liposomes Drug Delivery Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Liposomes Drug Delivery Market Share by Type in 2022 & 2029
Figure 4. Liposomal Doxorubicin Product Picture
Figure 5. Liposomal Amphoteracin B Product Picture
Figure 6. Liposomal Paclitaxel Product Picture
Figure 7. Others Product Picture
Figure 8. Global Liposomes Drug Delivery Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Liposomes Drug Delivery Market Share by Application in 2022 & 2029
Figure 10. Fungal Infection Therapy
Figure 11. Cancer & Tumor Therapy
Figure 12. Others
Figure 13. Global Liposomes Drug Delivery Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Liposomes Drug Delivery Market Size (2018-2029) & (US$ Million)
Figure 15. Global Liposomes Drug Delivery Sales (2018-2029) & (K Vials)
Figure 16. Global Liposomes Drug Delivery Average Price (USD/Vial) & (2018-2029)
Figure 17. Liposomes Drug Delivery Report Years Considered
Figure 18. Liposomes Drug Delivery Sales Share by Manufacturers in 2022
Figure 19. Global Liposomes Drug Delivery Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Liposomes Drug Delivery Players: Market Share by Revenue in 2022
Figure 21. Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Liposomes Drug Delivery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Liposomes Drug Delivery Sales Market Share by Country (2018-2029)
Figure 24. North America Liposomes Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Liposomes Drug Delivery Sales Market Share by Country (2018-2029)
Figure 28. Europe Liposomes Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 29. Germany Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Liposomes Drug Delivery Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Liposomes Drug Delivery Revenue Market Share by Region (2018-2029)
Figure 36. China Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Liposomes Drug Delivery Sales Market Share by Country (2018-2029)
Figure 46. Latin America Liposomes Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Liposomes Drug Delivery Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Liposomes Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Liposomes Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Liposomes Drug Delivery by Type (2018-2029)
Figure 56. Global Revenue Market Share of Liposomes Drug Delivery by Type (2018-2029)
Figure 57. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2018-2029)
Figure 58. Global Sales Market Share of Liposomes Drug Delivery by Application (2018-2029)
Figure 59. Global Revenue Market Share of Liposomes Drug Delivery by Application (2018-2029)
Figure 60. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2018-2029)
Figure 61. Liposomes Drug Delivery Value Chain
Figure 62. Liposomes Drug Delivery Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Gold Nanoparticles Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121
    Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......
  • Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......
  • Global Gold Nanoparticles Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......
  • Global Liposome Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......
  • Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......
  • Global Liposomes Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......
  • Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129
    According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......
  • Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs